中性粒细胞通过释放MMP-9促进银屑病血管扩张与通透性
该研究探讨中性粒细胞经内皮迁移过程中与皮肤血管内皮细胞的相互作用。研究发现银屑病中性粒细胞高表达并分泌有活性的MMP-9,通过ERK1/2与p38-MAPK通路激活血管内皮细胞,增强CD4+ T细胞跨内皮迁移;MMP-9抑制剂可减轻咪喹莫特或IL-23诱导小鼠模型的血管扩张、血管通透性及银屑病症状。
要点
- 中性粒细胞与皮肤血管内皮细胞在跨内皮迁移中相互激活
- 中性粒细胞来源MMP-9经ERK1/2和p38-MAPK激活内皮细胞
- MMP-9抑制剂可减轻银屑病样小鼠模型的血管改变与症状
核心结论
- 中性粒细胞来源的MMP-9通过激活皮肤血管内皮细胞诱导血管扩张和高通透性,从而促进银屑病皮损发展。
研究设计与样本
- 研究结合体内与体外实验,采用微阵列基因表达谱和酶谱法检测银屑病中性粒细胞MMP-9表达与活性。
- 使用咪喹莫特或IL-23诱导的银屑病样小鼠模型评估MMP-9抑制剂的效应。
主要发现
- 中性粒细胞和皮肤血管内皮细胞在中性粒细胞穿过皮肤内皮屏障时相互激活。
- 中性粒细胞浸润皮肤病变引起血管重塑,包括皮肤血管扩张和血管通透性增强。
- 微阵列数据显示MMP-9在银屑病中性粒细胞中过表达,酶谱法验证了其分泌MMP-9的生物活性。
- MMP-9通过ERK1/2和p38-MAPK信号通路激活血管内皮细胞,体外增强CD4+ T细胞跨内皮迁移。
- MMP-9抑制剂显著减少咪喹莫特或IL-23诱导银屑病样小鼠模型的皮肤血管扩张、血管通透性和银屑病症状。
关键数值与推荐
- MMP-9在银屑病中性粒细胞中过表达,其分泌的MMP-9具有生物活性。
- MMP-9经细胞外信号调节激酶1/2和p38-MAPK通路激活血管内皮细胞。
- MMP-9抑制剂在咪喹莫特或IL-23诱导银屑病样小鼠模型中显著减轻血管扩张、血管通透性和银屑病症状。
临床怎么用
- 提示中性粒细胞来源MMP-9及血管内皮激活可能成为银屑病治疗的潜在干预靶点。
- MMP-9抑制剂在动物模型中改善银屑病样症状,为后续临床转化研究提供依据。
局限性
- 证据主要来自体外实验和咪喹莫特或IL-23诱导的小鼠模型,尚缺乏人体临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neutrophil infiltration and papillary vessel dilation are hallmarks of the initiation phase of psoriatic lesions. However, how neutrophils aggravate psoriasis development during transendothelial migration and the interaction between neutrophils and cutaneous vascular endothelial cells are less well-understood. In this study, we reported that neutrophils and cutaneous vascular endothelial cells activated each other when neutrophils migrated through the cutaneous endothelial barrier. In addition, neutrophil infiltration into skin lesions caused vascular remodeling including cutaneous vasodilation and enhanced vascular permeability in vivo and in vitro. Microarray gene profile data showed that matrix metallopeptidase (MMP)-9 was overexpressed in psoriatic neutrophils, and zymography assay further validated the bioactivity of MMP-9 secreted by psoriatic neutrophils. Moreover, MMP-9 activated vascular endothelial cells through the extracellular signal‒regulated kinase 1/2 and p38-MAPK signaling pathways, enhancing CD4+ T-cell transmigration in vitro. Correspondingly, an MMP-9 inhibitor significantly reduced cutaneous vasodilation, vascular permeability, and psoriatic symptoms in an imiquimod- or IL-23‒induced psoriasiform mouse model. Overall, our study demonstrates that neutrophil-derived MMP-9 induces cutaneous vasodilation and hyperpermeability by activating cutaneous vascular endothelial cells, thus facilitating psoriatic lesion development, which increases our knowledge on the role of neutrophils in the pathogenesis of psoriasis.
引用
- Chen J, Zhu Z, Li Q, et al. Neutrophils Enhance Cutaneous Vascular Dilation and Permeability to Aggravate Psoriasis by Releasing Matrix Metallopeptidase 9. J Invest Dermatol. 2020. PMID: 32888954. doi:10.1016/j.jid.2020.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。